Patent · US Expired

Fusion polypeptides capable of activating receptors

US7534604B2 · kind B2 · utility

35Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 2005
Grant dateMay 19, 2009
Priority date
Expiry dateMar 22, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A fusion polypeptide comprising (A)x-M-(A′)y, wherein A and A′ are each polypeptides capable of binding a target receptor. The fusion polypeptides of the invention form multimeric proteins which activate the target receptor. A and A′ may be each be an antibody or fragment derived from an antibody specific for a target receptor, such as the same or different ScFv fragments, and/or a ligand or ligand fragment or derivative capable of binding the target protein, M is a multimerizing component, and X and Y are independently a number between 1-10.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.